SE403781B - Sett att framstella 15 alfa, 16 alfa-metylen-4-ostren- 17 beta-oler - Google Patents
Sett att framstella 15 alfa, 16 alfa-metylen-4-ostren- 17 beta-olerInfo
- Publication number
- SE403781B SE403781B SE7301935A SE7301935A SE403781B SE 403781 B SE403781 B SE 403781B SE 7301935 A SE7301935 A SE 7301935A SE 7301935 A SE7301935 A SE 7301935A SE 403781 B SE403781 B SE 403781B
- Authority
- SE
- Sweden
- Prior art keywords
- alfa
- ostrene
- oles
- methylene
- beta
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2207421A DE2207421C3 (de) | 1972-02-11 | 1972-02-11 | 15α, 16α -Methylen-4-östren-17β -ole bzw. -acylate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE403781B true SE403781B (sv) | 1978-09-04 |
Family
ID=5836211
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7301935A SE403781B (sv) | 1972-02-11 | 1973-02-12 | Sett att framstella 15 alfa, 16 alfa-metylen-4-ostren- 17 beta-oler |
| SE7514513A SE409329B (sv) | 1972-02-11 | 1975-12-22 | 15 alfa, 16 alfa-metylen-4-ostren-17 beta-oler till anvendning som kontraceptionsmedel |
| SE7713896A SE426834B (sv) | 1972-02-11 | 1977-12-07 | Sett att framstella 15alfa, 16alfa-metylen-4-ostren-17beta-oler |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7514513A SE409329B (sv) | 1972-02-11 | 1975-12-22 | 15 alfa, 16 alfa-metylen-4-ostren-17 beta-oler till anvendning som kontraceptionsmedel |
| SE7713896A SE426834B (sv) | 1972-02-11 | 1977-12-07 | Sett att framstella 15alfa, 16alfa-metylen-4-ostren-17beta-oler |
Country Status (29)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102007027637A1 (de) | 2007-06-12 | 2008-12-18 | Bayer Schering Pharma Aktiengesellschaft | 17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
| DE102007027636A1 (de) | 2007-06-12 | 2008-12-18 | Bayer Schering Pharma Aktiengesellschaft | 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT274653B (de) * | 1966-11-10 | 1969-09-25 | Alexander Schoeller & Co Kg | Stapelbarer, quaderförmiger, geschlossener Transportbehälter aus Kunststoff für feinkörnige Schüttgüter und Flüssigkeiten |
-
0
- BE BE795241D patent/BE795241A/xx not_active IP Right Cessation
-
1972
- 1972-02-11 DE DE2207421A patent/DE2207421C3/de not_active Expired
- 1972-12-29 PL PL1972159970A patent/PL81084B1/pl unknown
-
1973
- 1973-01-11 DD DD168198A patent/DD102379A5/xx unknown
- 1973-01-16 DK DK24273AA patent/DK131037B/da not_active IP Right Cessation
- 1973-01-23 FI FI730169A patent/FI52225C/fi active
- 1973-01-24 ES ES410933A patent/ES410933A1/es not_active Expired
- 1973-01-31 CS CS73748A patent/CS193019B2/cs unknown
- 1973-01-31 YU YU243/73A patent/YU35035B/xx unknown
- 1973-02-06 CA CA163,029A patent/CA997753A/en not_active Expired
- 1973-02-06 IE IE190/73A patent/IE37266B1/xx unknown
- 1973-02-07 EG EG49/73A patent/EG10914A/xx active
- 1973-02-08 AT AT112473A patent/AT327413B/de not_active IP Right Cessation
- 1973-02-09 PH PH14330*UA patent/PH9370A/en unknown
- 1973-02-09 CH CH186373A patent/CH590883A5/xx not_active IP Right Cessation
- 1973-02-09 IL IL41506A patent/IL41506A/en unknown
- 1973-02-09 NO NO528/73A patent/NO140304C/no unknown
- 1973-02-09 CH CH535776A patent/CH593995A5/xx not_active IP Right Cessation
- 1973-02-09 GR GR1318A patent/GR63160B/el unknown
- 1973-02-09 SU SU1891803A patent/SU513628A3/ru active
- 1973-02-09 FR FR7304678A patent/FR2181719B1/fr not_active Expired
- 1973-02-09 ZA ZA730944A patent/ZA73944B/xx unknown
- 1973-02-10 KR KR7300246A patent/KR780000156B1/ko active
- 1973-02-10 HU HUSE1666A patent/HU165253B/hu unknown
- 1973-02-10 RO RO7373805A patent/RO73527A/ro unknown
- 1973-02-12 SE SE7301935A patent/SE403781B/xx unknown
- 1973-02-12 AU AU52076/73A patent/AU467306B2/en not_active Expired
- 1973-02-12 GB GB682173A patent/GB1425636A/en not_active Expired
- 1973-02-12 JP JP48017357A patent/JPS5829317B2/ja not_active Expired
- 1973-02-12 NL NLAANVRAGE7301974,A patent/NL177217C/xx not_active IP Right Cessation
-
1975
- 1975-12-22 SE SE7514513A patent/SE409329B/xx not_active IP Right Cessation
-
1977
- 1977-12-07 SE SE7713896A patent/SE426834B/sv not_active IP Right Cessation
-
1978
- 1978-08-14 NO NO782754A patent/NO143065C/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT988869B (it) | Procedimento per la produzione di n fosfonometilglicina | |
| IT1001432B (it) | Procedimento per produrre n fosfonometilglicina | |
| SE7408486L (sv) | Sett att framstella poperazinyl-kinoxalinforeningar. | |
| SU447888A3 (ru) | Способ получения бензо-1,2,4-триазинди- -окисей-(1,4) | |
| SE403478B (sv) | Sett att framstella 2,2,6,6-tetrametyl-4-oxopiperidin | |
| SE392103B (sv) | Sett att framstella 1,2-bensisotiazolin-3-oner | |
| IT1034585B (it) | Procedimento per la produzione di 2.3 diidrossipropilcellulosa | |
| SE385707B (sv) | Sett att framstella 8,9-didehydro-10-alkoxi-ergolenderivat | |
| SE382636B (sv) | Sett att framstella kombinerade, mjukelastiska lettplaster | |
| SE385591B (sv) | Sett att framstella 16,17- omettade steroider tillhorande pregnanserien | |
| SE397190B (sv) | Sett att framstella substituerade dibensocykloheptener | |
| SE385903B (sv) | Sett att framstella 3,16alfa,17xi-trihydroxi-11beta-alkoxi-ostra-1,3,5 (10)- triener | |
| SE409458B (sv) | Sett att framstella 7-amino-desacetoxi-cefalosporansyra | |
| SE403781B (sv) | Sett att framstella 15 alfa, 16 alfa-metylen-4-ostren- 17 beta-oler | |
| SE405118B (sv) | Sett att framstella 2,4-diamino-5-bensylpyrimidiner | |
| SE404192B (sv) | Sett att framstella 3 beta-cykloalkyloxi-16 alfa-cyanopregn-5-en-20-oner | |
| SE393384B (sv) | Sett att framstella 15 alfa, 16 alfa-metylen-4-pregnener | |
| IT997554B (it) | Procedimento per la produzione di 2 5 esandione | |
| BE799383A (fr) | Production d'elastomeres, | |
| SE387111B (sv) | Sett att framstella bensoylfenylguanidiner | |
| IT942218B (it) | Procedimento per la produzione di pezzi stampati di poliammide | |
| SU499814A3 (ru) | Способ получени 13 -этил-17 -этинил-гон-4-ен-3-он-17 -ола | |
| SE396751B (sv) | Sett att framstella s?72iv-benso-1,2,4-tiadiaziner | |
| SE385012B (sv) | Sett att framstella 4,9,11 - trien-steroid-derivat | |
| SE389110B (sv) | Sett att framstella 1-aryl-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-2-oner |